Charles Ryhee
Stock Analyst at TD Cowen
(1.98)
# 3,030
Out of 4,945 analysts
25
Total ratings
52.38%
Success rate
1.18%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $66.73 | +19.89% | 5 | Nov 25, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $12.04 | +16.28% | 6 | Oct 22, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $673.82 | -3.24% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $155.16 | +9.56% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $8.82 | +568.93% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $150.22 | -52.07% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $0.37 | +216,015.26% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $7.30 | +2,475.34% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $14.68 | +97.55% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $66.73
Upside: +19.89%
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $12.04
Upside: +16.28%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $673.82
Upside: -3.24%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $155.16
Upside: +9.56%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $8.82
Upside: +568.93%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $150.22
Upside: -52.07%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $0.37
Upside: +216,015.26%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $7.30
Upside: +2,475.34%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $14.68
Upside: +97.55%